Cargando…
Hypertension and its management in COVID-19 patients: The assorted view
BACKGROUND: Coronavirus disease 2019 (COVID-19) is suspected to mainly be more deleterious in patients with underlying cardiovascular diseases (CVD). There is a strong association between hypertension and COVID-19 severity. The binding of SARS-CoV-2 to the angiotensin-converting enzyme 2 (ACE2) lead...
Autores principales: | Batiha, Gaber El-Saber, Gari, Abdulrahim, Elshony, Norhan, Shaheen, Hazem M., Abubakar, Murtala Bello, Adeyemi, Sherif Babatunde, Al-kuraishy, Hayder M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590508/ https://www.ncbi.nlm.nih.gov/pubmed/34806090 http://dx.doi.org/10.1016/j.ijcrp.2021.200121 |
Ejemplares similares
-
Common NLRP3 inflammasome inhibitors and Covid-19: Divide and conquer
por: Batiha, Gaber El-Saber, et al.
Publicado: (2022) -
The possible role of ursolic acid in Covid-19: A real game changer
por: Al-kuraishy, Hayder M., et al.
Publicado: (2022) -
The crucial role of prolactin-lactogenic hormone in Covid-19
por: Al-Kuraishy, Hayder M., et al.
Publicado: (2022) -
COVID-19 and erythrocrine function: The roller coaster and
danger
por: Al-kuraishy, Hayder M, et al.
Publicado: (2022) -
Dipyridamole and adenosinergic pathway in Covid-19: a juice or holy grail
por: Al-kuraishy, Hayder M., et al.
Publicado: (2022)